Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
abscess, intracranial
adverse drug reaction
amyloidosis
amyotrophic lateral sclerosis, guamian type of
aneurysm
aneurysm, giant cerebral
aneurysm, intracranial
aneurysm, intracranial, familial
angiofibroma, facial
angiomyolipomas
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, untoward effects of
arrhythmia, cardiac
ash leaf spots
astrocytoma
asymptomatic
atrial myxoma
attention deficit disorder with hyperactivity
autism
autistic behavior
basal ganglia
basal ganglia, calcification of
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavior
behavioral disorder
blindness
cafe au lait spots
calcification, intracranial
carbamazepine
carbon monoxide poisoning
carcinoma
cardiac tumor
cardiomyopathy
CAT scan
CAT scan, abnormal
CAT scan, abscess, cerebral
CAT scan, brain scan compared to
CAT scan, brain tumors
CAT scan, cerebrovascular disease
CAT scan, chest
CAT scan, dementia
CAT scan, demyelinating disease
CAT scan, emission
CAT scan, metrizamide
CAT scan, spinal cord
caudate nucleus, lesion of
cavernous hemangioma
cerebellar lesion
cerebral embolism
cerebral venous thrombosis, deep
cerebrovascular accident
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, young adult
chemotherapy, CNS treatment and complications with
children
chromosomal abnormality
chromosome 16
chromosome 9
Clinical Pathologic Conference(C.P.C.)
coagulopathy
cognition
corpus callosotomy
craniopharyngioma
cyanide poison
cyst, cortical parenchyma
deep gray nuclei
degenerative diseases of CNS
dementia
demyelinating disease
developmental milestones, loss of
developmental retardation
efficacy
Ehlers-Danlos syndrome
electrocardiogram, abnormal
electroencephalogram
encephalitis
ependymoma
everolimus
exophthalmus
Fabry's disease
familial
fibroma, ungual
fibromuscular dysplasia
fibrous dysplasia
fundus, abnormality of
funduscopic exam
gadolinium
gene
gene mutation
genetic counselling
genetic neurologic disorders
genetic screening
genetic testing
gingival hyperplasia
Hallervorden Spatz disease
hamartin
hamartoma
headache
heart block
hemangioma
hemoglobin abnormality, neurologic complications of
hereditary hemorrhagic telangiectasia(HHT)
herpes virus infection
homocystinuria
human immunodeficiency virus type 1
hydrocephalus
hydrocephalus, non-communicating(obstructive)
hypopigmentation of skin
hypothalamus, disturbance of
hypothalamus, neoplasm of
hypsarrhythmia
infantile spasm
intellectual deficit
intracerebral hemorrhage
intracerebral hemorrhage, young adult
intracranial hemorrhage
intracranial pressure, increased
Jakob-Creutzfeldt disease
lead poisoning
lenticular nucleus, lesion of, bilateral
life expectancy
lymphangiomyomatosis
malformation, CNS, congenital
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, familial
MELAS syndrome
meningitis
meningitis, TB
mental retardation
mental retardation, familial
methanol intoxication
migraine
migraine, hemiplegic
mitral valve prolapse
molecular genetics
mongolism
mortality
moyamoya
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, diffusion weighted
MRI, fetal
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS, hemorrhagic
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurocutaneous disease
neurofibrillary degeneration
neurofibromatosis 1
neurologic disease, diagnoses of
neuronal ceroid-lipofuscinosis
neuronal migration disorder
neuropathology
neuropathology, brain
neurotoxin
optic glioma
optic nerve
optic nerve, lesion of
orbit
papilledema
paraparesis, familial spastic
Parkinson disease, postencephalitic
phakomatoses
pineal, neoplasm
pinealoma
polycystic kidneys
polycythemia, primary
polyps, gastrointestinal tract
practice guidelines
precocious puberty
prognosis
protein C deficiency
pseudoxanthoma elasticum
putamen, lesion of, bilateral
quality of life
radiation therapy, CNS treatment and complications with
renal cyst
renal failure
retinal hamartoma
retinal lesion
retinal tumor
review article
rhabdomyoma, cardiac
rhabdomyosarcoma of heart
rickets
safety
screening
seizure
seizure, children
seizure, familial
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, minor motor
seizure, psychomotor-temporal lobe
seizure, skin lesion associated with
seizure, surgical treatment of
seizure, treatment of
shagreen patch
sickle cell disease
skin, lesions in neurologic disorders
spinal cord, vascular malformation of
status epilepticus
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of, bilateral
Sturge-Weber syndrome
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subdural hematoma
subependymal nodules
symmetric brain lesions
syphilis, congenital
syringomyelia
temporal lobe
temporal lobe, lesion
teratoma
thalamus, lesion of-bilateral
third ventricle, mass of
thrombocytopenia
toxoplasmosis, CNS
treatment of neurologic disorder
tuber, cortical
tuberin
tuberous sclerosis
tuberous sclerosis, screening for
ultrasonography
uremic encephalopathy
viral infection, CNS
visual loss
Von Hippel Lindau
web sites
Werdnig-Hoffman disease
West disease
white freckles
white matter disease
Wood's light
Showing articles 550 to 600 of 2352 << Previous Next >>

Spinal Muscular Atrophy
Lancet 371:2120-2133, Lunn,M.R. &Wang,C.H., 2008

Effect of Laquinimod on MRI-Monitored Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study
Lancet 371:2085-2092,2059, Comi,G.,etc., 2008

Clinicopath Conf., Endheim-Chester Disease
NEJM 359:736-747, Case 25-2008, 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Four New Cases of Therapy-Related Acute Promyelocytic Leukemia After Mitoxantrone
Neurol 71:457-458, Bosca,I.,et al., 2008

Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score
Stroke 39:2304-2309, Rost,N.S.,et al., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Multiple Sclerosis and Cannabis: A Cognitive and Psychiatric Study
Neurol 71:164-169, Ghaffar,O. &Feinstein,A., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Genetics of Familial Amyotrophic Lateral Sclerosis
Neurol 70:144-152, Valdmanis,P.N. &Rouleau,G.A., 2008

Unexpected Multiple Sclerosis: Follow-Up of 30 Patients With Magnetic Resonance Imaging and Clinical Conversion Profile
JNNP 79:195-198,112, Lebrun,C.,et al, 2008

Primary Lateral Sclerosis With HIV-1 Infection
Neurol 70:575-577, Verma,A. &Berger,J.R., 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 69:1552-1553, Sorenson,P.S. &Bertolotto,A., 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

NMO-IgG in the Diagnosis of Neuromyelitis Optica
Neurol 68:1076-1077, Jarius,S.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007

Orthostatic Myoclonus: A Contributor to Gait Decline in Selected Elderly
Neurol 68:1826-1830, Glass,G.A.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Electromyographic Biofeedback for the Recovery of Motor Function After Stroke
Stroke 38:1999-2000, Woodford,H.J. &Price,C., 2007

Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007

Natural History of Multiple Sclerosis with Childhood Onset
NEJM 356:2603-2613, Renoux,C.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Neuropsychiatric Syndromes Associated With Multiple Sclerosis
J Neurol 254:II/73-II/76, Feinstein,A., 2007

Palliative Care for Patients With Amyotrophic Lateral Sclerosis
JAMA 298:207-216,248, Mitsumoto,H. &Rabkin,J.G., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Rehabilitation for Spatial Neglect Improves Test Performance But Not Disability
Stroke 38:2869-2870, Bowen,A. &Lincoln,N.B., 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Parental Transmission of MS in a Population-Based Canadian Cohort
Neurol 69:1208-1212,1202, Herrera,B.M.,et al, 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

Limbic Encephalitis as a Precipitating Event in Adult-Onset Temporal Lobe Epilepsy
Neurol 69:1236-1244, Bien,C.G.,et al, 2007

Mangnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study: Integrated 2-Year Results
Arch Neurol 64:1292-1298, Barkhof,F.,et al, 2007



Showing articles 550 to 600 of 2352 << Previous Next >>